microdosing semaglutide vs tirzepatide Macrodosing GLP-1: The Risks of Taking Too Much — INTRA|V Tirzepatide Microdosing: Finding Your Right

According to the Joi + Blokes GLP-1 page, the most common side effects reported with semaglutide and tirzepatide include nausea, vomiting, diarrhea, constipation, bloating or gas, decreased appetite, and fatigue

These include nausea, vomiting, diarrhoea, constipation, abdominal discomfort, and reduced appetite, as documented in the UK SmPC

Such primary tumors have historically been referred to as malignant blue nevus

New findings confirm that Wegovy, a GLP-1R/GIPR-like agonist, modulates alcohol-related behaviours through reward-related mechanisms

Some patients prefer evening administration to sleep through potential gastrointestinal side effects like nausea, though no research definitively proves one timing superior to another